Pernod Ricard: Why I Am Not Worried About The Long-Term Upside

Despite a recent 25%+ share price decline driven by short-term sales weakness from tariffs and geopolitics, Pernod Ricard's fundamentals remain strong, supported by a 5% dividend, BBB+ rating, and low leverage. While recovery is projected to be delayed until 2027-2029, the stock's valuation is now considered attractive, with a fair value of €140/share and potential for 20%+ annualized returns upon recovery, leading to a "Buy" rating for diversified portfolios.

Analysis

Pernod Ricard's shares have experienced a significant downturn, declining by over 25%; however, this is viewed as overdone considering the company's robust underlying fundamentals. Despite short-term sales weakness attributed to tariffs and geopolitical factors, Pernod Ricard maintains a strong financial profile, highlighted by a secure 5% dividend yield, a BBB+ credit rating, and low leverage, which collectively provide stability. A full sales recovery is projected to be delayed, with expectations set for the 2027-2029 period. Nevertheless, the current stock valuation is considered attractive, with an analyst-assessed fair value of €140 per share and the potential for long-term annualized returns exceeding 20% once recovery initiates. Based on these factors, including its quality, established economic moat, and discounted price, Pernod Ricard is rated a 'Buy', especially for diversified portfolios or as a complement to investments in competitors like Diageo.

Key Decisions for Investors

• Investors with a long-term horizon should consider the recent share price decline of over 25% as an attractive entry point for Pernod Ricard, given its strong underlying fundamentals and a fair value estimate of €140 per share.
• The secure 5% dividend yield, supported by Pernod Ricard's BBB+ credit rating and low leverage, offers income potential for investors prepared to wait for the projected sales recovery between 2027 and 2029.
• Pernod Ricard is recommended as a 'Buy' for diversified portfolios, particularly as a complement to existing holdings in peers such as Diageo, due to its quality, competitive moat, and current discounted valuation, with an outlook for over 20% annualized returns post-recovery.
• It is crucial for investors to acknowledge the ongoing short-term headwinds from tariffs and geopolitical instability, which are expected to delay significant sales recovery, and therefore align their investment timeframe with the extended outlook.